Generics Competition Intense For Pharma Firms

22 September 1996

German management consultancy Roland Berger is forecasting a virtual doubling in the world generics market from around $14 million in 1994 to over $30 million by the year 2000. The forecast is based on a number of international sources pointing to generics growth in this period of 14% annually, compared with 6% for the drug market as a whole.

Generics are expected to increase their share of the market from 12.3% in 1994 to an average of 20.5% in 2000, with the US market alone expanding from $3.5 billion to $13 billion in value.

Berger says the trend is due to continuing downward pressure on costs in national health services. Growth is expected in well-established markets such as the USA, UK and Germany, but also in France, Sweden and Japan, where generics currently occupy a relatively minor role.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight